Genitourinary Radiology: Page 54

IMRT seems most effective radiation therapy for prostate cancer
By Cynthia E. Keen
The use of intensity-modulated radiation therapy (IMRT) for prostate cancer caused fewer toxicities and less cancer recurrence than conformal radiotherapy and proton therapy treatments, according to a study published in the April 18 issue of the Journal of the American Medical Association.
April 16, 2012
2012 04 20 11 08 21 212 Chen Imrt Prostate 450
USHIFU touts Lancet study results
By AuntMinnie.com staff writers
High-intensity focused ultrasound (HIFU) developer USHIFU is touting study results published online in Lancet Oncology. The results suggest that using HIFU to deliver focal treatment for prostate cancer could provide an alternative to traditional treatment with significantly fewer side effects, according to the company.
April 16, 2012
Radiology's early martyrs; self-referral and IMRT costs; ABUS gets a nod
By Brian Casey
April 11, 2012
Study: IMRT for prostate cancer may be overused
By Cynthia E. Keen
A study published in the April issue of Health Affairs comparing two types of effective radiotherapy treatments for prostate cancer found that intensity-modulated radiation therapy (IMRT), the more expensive of the two, may be overused.
April 11, 2012
SIR: New prostate treatment shows promise
By AuntMinnie.com staff writers
A new interventional radiology treatment known as prostatic artery embolization may help men with debilitating symptoms caused by an enlarged prostate, according to a study presented at this week's Society of Interventional Radiology (SIR) annual meeting in San Francisco.
March 26, 2012
Elekta gets FDA OK for ultrasound option
By AuntMinnie.com staff writers
Oncology firm Elekta has received 510(k) clearance from the U.S. Food and Drug Administration for an autoscan option that allows remote, automated ultrasound scanning with Elekta's Clarity soft-tissue visualization system.
February 20, 2012
Choline-PET/CT changes prostate cancer treatment plans
By Wayne Forrest
Swiss researchers have found that PET/CT scans with the radiopharmaceutical choline can change treatment plans for certain patients with recurrent prostate cancer. Study results showed that choline-PET/CT significantly affected therapy management.
February 9, 2012
ACR partners on prostate cancer initiative
By AuntMinnie.com staff writers
To improve early diagnosis and treatment of prostate cancer, the American College of Radiology (ACR), the AdMeTech Foundation, and the European Society of Urogenital Radiology have formed a joint effort to expedite the development of standards for the Magnetic Resonance Prostate Imaging Reporting and Data System.
February 7, 2012
IsoRay touts Cleveland Clinic study
By AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical is touting a Cleveland Clinic study that found brachytherapy to have the fewest toxicities involving genital or urinary organs and the lowest total cost per patient, per year.
February 6, 2012
Contrast face-off reveals little difference in renal function
By Eric Barnes
A large comparison of two commonly used low-osmolality contrast agents failed to find significant differences in their effect on kidney function, according to a new study in the February issue of the American Journal of Roentgenology.
February 5, 2012
Ultrasound finds, treats kidney stones
By AuntMinnie.com staff writers
Scientists from the National Space Biomedical Research Institute are developing ultrasound technology that can detect and "push" kidney stones toward the exit of the kidney.
January 31, 2012
Molecular Insight inks radiopharma deal
By AuntMinnie.com staff writers
Radiopharmaceutical developer Molecular Insight Pharmaceuticals has signed an agreement with the Centre for Probe Development and Commercialization to manufacture a new radiopharmaceutical designed to deliver therapeutic doses of radiation directly to metastatic prostate cancer.
January 30, 2012
Previous Page
Page 54 of 96
Next Page